Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Hypha Labs (FUNI) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Hypha Labs (FUNI) over the last 16 years, with Q2 2025 value amounting to $137.0 million.

  • Hypha Labs' Shares Outstanding (Weighted Average) rose 2712.39% to $137.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $137.0 million, marking a year-over-year increase of 2712.39%. This contributed to the annual value of $101.3 million for FY2024, which is 2076.03% up from last year.
  • Per Hypha Labs' latest filing, its Shares Outstanding (Weighted Average) stood at $137.0 million for Q2 2025, which was up 2712.39% from $131.1 million recorded in Q1 2025.
  • Hypha Labs' Shares Outstanding (Weighted Average)'s 5-year high stood at $137.0 million during Q2 2025, with a 5-year trough of $65.4 million in Q1 2021.
  • Over the past 5 years, Hypha Labs' median Shares Outstanding (Weighted Average) value was $83.1 million (recorded in 2023), while the average stood at $89.4 million.
  • As far as peak fluctuations go, Hypha Labs' Shares Outstanding (Weighted Average) surged by 593.26% in 2023, and later skyrocketed by 4307.93% in 2024.
  • Quarter analysis of 5 years shows Hypha Labs' Shares Outstanding (Weighted Average) stood at $72.4 million in 2021, then grew by 13.58% to $82.2 million in 2022, then rose by 5.93% to $87.1 million in 2023, then skyrocketed by 43.08% to $124.6 million in 2024, then rose by 9.9% to $137.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $137.0 million in Q2 2025, compared to $131.1 million in Q1 2025 and $124.6 million in Q4 2024.